REVA MEDICAL ANNOUNCES INITIATION OF ENROLLMENT IN THE MOTIV IDE CLINCIAL TRIAL
/PRNewswire/ -- REVA Medical, LLC, a leader in bioresorbable polymer technologies for vascular applications, today announced that enrollment in the MOTIV...
Stay updated with breaking news from Fantom Encore. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- REVA Medical, LLC, a leader in bioresorbable polymer technologies for vascular applications, today announced that enrollment in the MOTIV...
SAN DIEGO, Sept. 27, 2022 /PRNewswire/ -- REVA Medical, LLC, a leader in bioresorbable polymer technologies for vascular applications, today
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
/PRNewswire/ -- REVA Medical, LLC. ("REVA" or the "Company"), a leader in bioresorbable polymer technologies for vascular applications, is pleased to announce...
SAN DIEGO, Aug. 9, 2022 /PRNewswire/ -- REVA Medical, LLC. ("REVA" or the "Company"), a leader in bioresorbable polymer technologies for vascular applications, is pleased to announce the closing